Real-world effectiveness & safety of fremanezumab in migraine: 3rd interim analysis of the pan-European PEARL study

被引：0

作者：

Ashina, M. ^{[1
,2
]}

Mitsikostas, D. ^{[3
]}

Amin, F. ^{[1
,4
]}

Kokturk, P. ^{[5
]}

Schankin, C. ^{[6
]}

Sahin, G. ^{[7
]}

Pozo-Rosich, P. ^{[8
,9
]}

Dorman, P. ^{[10
]}

Nezadal, T. ^{[11
]}

Poole, A. ^{[12
]}

Martins, I. ^{[13
]}

Sumelahti, M. ^{[14
]}

Campos, V. Ramirez ^{[15
]}

Ning, X. ^{[15
]}

Lyras, L. ^{[5
]}

Tassorelli, C. ^{[16
,17
]}

机构：

[1] Copenhagen Univ Hosp, Rigshospitalet Glostrup, Danish Headache Ctr, Dept Neurol, Copenhagen, Denmark

[2] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark

[3] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Dept Neurol 1, Athens, Greece

[4] Univ Copenhagen, Rigshospitalet Glostrup, Dept Neurorehabil Traumat Brain Injury, Copenhagen, Denmark

[5] Teva Netherlands BV, Amsterdam, Netherlands

[6] Univ Bern, Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland

[7] Lund Univ, Dept Clin Sci Lund, Skaneuro Neurol Clin, Lund, Sweden

[8] Univ Autonoma Barcelona, Vall Hebron Hosp, Headache Unit, Barcelona, Spain

[9] Univ Autonoma Barcelona, Res Inst, Res Grp, Barcelona, Spain

[10] Newcastle Tyne Hosp NHS Fdn Trust, Newcastle, NSW, Australia

[11] Charles Univ Prague, Inst Neuropsychiat Care, Ist Sch Med, Prague, Czech Republic

[12] Oslo Headache Ctr, Private Practice, Oslo, Norway

[13] Univ Lisbon, Centro Estudos Egas Moniz, Fac Med, Lisbon, Portugal

[14] Univ Tampere, Fac Med & Hlth Technol, Tampere, Finland

[15] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA

[16] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy

[17] IRCCS Mondino Fdn, Pavia, Italy

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EPR-045

引用

页码：149 / 150

页数：2